{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:05:54Z","timestamp":1793664354241,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8061","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.1038\/s41586-025-08758-w","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T14:12:32Z","timestamp":1742998352000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["STING agonist-based ER-targeting molecules boost antigen cross-presentation"],"prefix":"10.1038","volume":"641","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1575-0010","authenticated-orcid":false,"given":"Xiafeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9705-5419","authenticated-orcid":false,"given":"Zhangping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3027-1325","authenticated-orcid":false,"given":"Lixiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3435-1200","authenticated-orcid":false,"given":"Liru","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6419-4109","authenticated-orcid":false,"given":"Juan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiguanxi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-8444","authenticated-orcid":false,"given":"Xi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-7472","authenticated-orcid":false,"given":"Xiaojun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0395-2800","authenticated-orcid":false,"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-7135","authenticated-orcid":false,"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-4425","authenticated-orcid":false,"given":"Yingyue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0391","authenticated-orcid":false,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-3264","authenticated-orcid":false,"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"8758_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","volume":"3","author":"MJ Lin","year":"2022","unstructured":"Lin, M. J. et al. Cancer vaccines: the next immunotherapy frontier. Nat. Cancer 3, 911\u2013926 (2022).","journal-title":"Nat. Cancer"},{"key":"8758_CR2","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science 367, eaau0810 (2020).","DOI":"10.1126\/science.aau0810"},{"key":"8758_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1126\/science.add2897","volume":"377","author":"EJ Wherry","year":"2022","unstructured":"Wherry, E. J. & Barouch, D. H. T cell immunity to COVID-19 vaccines. Science 377, 821\u2013822 (2022).","journal-title":"Science"},{"key":"8758_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-immunol-041015-055254","volume":"35","author":"FM Cruz","year":"2017","unstructured":"Cruz, F. M., Colbert, J. D., Merino, E., Kriegsman, B. A. & Rock, K. L. The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules. Annu. Rev. Immunol. 35, 149\u2013176 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"8758_CR5","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars, M. C., Wu, C. J. & Fritsch, E. F. Cancer vaccines: building a bridge over troubled waters. Cell 185, 2770\u20132788 (2022).","journal-title":"Cell"},{"key":"8758_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"8758_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41565-018-0274-0","volume":"13","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Physical activation of innate immunity by spiky particles. Nat. Nanotechnol. 13, 1078\u20131086 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"8758_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct. Target. Ther. 8, 283 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"8758_CR9","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/1521-4141(2000)30:8<2115::AID-IMMU2115>3.0.CO;2-J","volume":"30","author":"BR Minev","year":"2000","unstructured":"Minev, B. R., Chavez, F. L., Dudouet, B. M. & Mitchell, M. S. Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1. Eur. J. Immunol. 30, 2115\u20132124 (2000).","journal-title":"Eur. J. Immunol."},{"key":"8758_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2006.10.011","volume":"117","author":"A Hayashi","year":"2007","unstructured":"Hayashi, A. et al. A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity. J. Control. Release 117, 11\u201319 (2007).","journal-title":"J. Control. Release"},{"key":"8758_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.174.2.489","volume":"174","author":"K Anderson","year":"1991","unstructured":"Anderson, K. et al. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174, 489\u2013492 (1991).","journal-title":"J. Exp. Med."},{"key":"8758_CR12","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1021\/mp200198c","volume":"8","author":"H Sneh-Edri","year":"2011","unstructured":"Sneh-Edri, H., Likhtenshtein, D. & Stepensky, D. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. Mol. Pharm. 8, 1266\u20131275 (2011).","journal-title":"Mol. Pharm."},{"key":"8758_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"8758_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826\u2013830 (2013).","journal-title":"Science"},{"key":"8758_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.molcel.2012.05.029","volume":"46","author":"Q Yin","year":"2012","unstructured":"Yin, Q. et al. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol. Cell 46, 735\u2013745 (2012).","journal-title":"Mol. Cell"},{"key":"8758_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu, J. M. et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 564, 439\u2013443 (2018).","journal-title":"Nature"},{"key":"8758_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.abb4255","volume":"369","author":"EN Chin","year":"2020","unstructured":"Chin, E. N. et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science 369, 993\u2013999 (2020).","journal-title":"Science"},{"key":"8758_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226\u2013235 (2013).","journal-title":"Mol. Cell"},{"key":"8758_CR19","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/eji.201343324","volume":"43","author":"RA Rosalia","year":"2013","unstructured":"Rosalia, R. A. et al. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation. Eur. J. Immunol. 43, 2554\u20132565 (2013).","journal-title":"Eur. J. Immunol."},{"key":"8758_CR20","doi-asserted-by":"publisher","first-page":"15867","DOI":"10.1002\/chem.202003951","volume":"26","author":"M Lahnsteiner","year":"2020","unstructured":"Lahnsteiner, M. et al. Improving the stability of maleimide-thiol conjugation for drug targeting. Chemistry 26, 15867\u201315870 (2020).","journal-title":"Chemistry"},{"key":"8758_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/eji.200737995","volume":"38","author":"MS Bijker","year":"2008","unstructured":"Bijker, M. S. et al. Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation. Eur. J. Immunol. 38, 1033\u20131042 (2008).","journal-title":"Eur. J. Immunol."},{"key":"8758_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41563-018-0256-5","volume":"18","author":"DS Wilson","year":"2019","unstructured":"Wilson, D. S. et al. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat. Mater. 18, 175\u2013185 (2019).","journal-title":"Nat. Mater."},{"key":"8758_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.732450","volume":"12","author":"YS Lee","year":"2021","unstructured":"Lee, Y. S. et al. Peptides derived from S and N proteins of severe acute respiratory syndrome coronavirus 2 induce T cell responses: a proof of concept for T cell vaccines. Front. Microbiol. 12, 732450 (2021).","journal-title":"Front. Microbiol."},{"key":"8758_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2019.05.036","volume":"178","author":"SL Ergun","year":"2019","unstructured":"Ergun, S. L., Fernandez, D., Weiss, T. M. & Li, L. STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition. Cell 178, 290\u2013301.e10 (2019).","journal-title":"Cell"},{"key":"8758_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature 567, 394\u2013398 (2019).","journal-title":"Nature"},{"key":"8758_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41556-021-00659-0","volume":"23","author":"X Yu","year":"2021","unstructured":"Yu, X. et al. The STING phase-separator suppresses innate immune signalling. Nat. Cell Biol. 23, 330\u2013340 (2021).","journal-title":"Nat. Cell Biol."},{"key":"8758_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature12640","volume":"503","author":"A Ablasser","year":"2013","unstructured":"Ablasser, A. et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503, 530\u2013534 (2013).","journal-title":"Nature"},{"key":"8758_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"8758_CR29","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1038\/sj.emboj.7600731","volume":"24","author":"KU Kalies","year":"2005","unstructured":"Kalies, K. U., Allan, S., Sergeyenko, T., Kr\u00f6ger, H. & R\u00f6misch, K. The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. EMBO J. 24, 2284\u20132293 (2005).","journal-title":"EMBO J."},{"key":"8758_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag, S. M. et al. Targeting STING with covalent small-molecule inhibitors. Nature 559, 269\u2013273 (2018).","journal-title":"Nature"},{"key":"8758_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200\u2013208 (2023).","journal-title":"Nature"},{"key":"8758_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-021-03762-2","volume":"596","author":"TT Chu","year":"2021","unstructured":"Chu, T. T. et al. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C. Nature 596, 570\u2013575 (2021).","journal-title":"Nature"},{"key":"8758_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1126\/science.adf8974","volume":"381","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Human STING is a proton channel. Science 381, 508\u2013514 (2023).","journal-title":"Science"},{"key":"8758_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572\u2013576 (2014).","journal-title":"Nature"},{"key":"8758_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692\u2013696 (2015).","journal-title":"Nature"},{"key":"8758_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"8758_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2021","unstructured":"Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 22, 74\u201385 (2021).","journal-title":"Nat. Immunol."},{"key":"8758_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-022-00612-2","volume":"32","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs. Cell Res. 32, 269\u2013287 (2022).","journal-title":"Cell Res."},{"key":"8758_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N Hilf","year":"2019","unstructured":"Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240\u2013245 (2019).","journal-title":"Nature"},{"key":"8758_CR40","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","volume":"40","author":"MM Awad","year":"2022","unstructured":"Awad, M. M. et al. Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer. Cancer Cell 40, 1010\u20131026.e11 (2022).","journal-title":"Cancer Cell"},{"key":"8758_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0174-9","volume":"5","author":"O Pleguezuelos","year":"2020","unstructured":"Pleguezuelos, O. et al. Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study. NPJ Vaccines 5, 22 (2020).","journal-title":"NPJ Vaccines"},{"key":"8758_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","volume":"601","author":"JS Heitmann","year":"2022","unstructured":"Heitmann, J. S. et al. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature 601, 617\u2013622 (2022).","journal-title":"Nature"},{"key":"8758_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu, H. et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507, 519\u2013522 (2014).","journal-title":"Nature"},{"key":"8758_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","volume":"15","author":"A Schudel","year":"2020","unstructured":"Schudel, A. et al. Programmable multistage drug delivery to lymph nodes. Nat. Nanotechnol. 15, 491\u2013499 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"8758_CR45","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41563-020-0680-1","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Metabolic labeling and targeted modulation of dendritic cells. Nat. Mater. 19, 1244\u20131252 (2020).","journal-title":"Nat. Mater."},{"key":"8758_CR46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396\u2013401 (2016).","journal-title":"Nature"},{"key":"8758_CR47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","volume":"36","author":"S Jackson","year":"2018","unstructured":"Jackson, S. et al. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a Toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine 36, 668\u2013674 (2018).","journal-title":"Vaccine"},{"key":"8758_CR48","doi-asserted-by":"publisher","first-page":"eabn8934","DOI":"10.1126\/science.abn8934","volume":"379","author":"A Aung","year":"2023","unstructured":"Aung, A. et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization. Science 379, eabn8934 (2023).","journal-title":"Science"},{"key":"8758_CR49","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1182\/blood-2013-12-545772","volume":"124","author":"CT Mayer","year":"2014","unstructured":"Mayer, C. T. et al. Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. Blood 124, 3081\u20133091 (2014).","journal-title":"Blood"},{"key":"8758_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23244-3","volume":"12","author":"J Koerner","year":"2021","unstructured":"Koerner, J. et al. PLGA-particle vaccine carrying TLR3\/RIG-I ligand riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nat. Commun. 12, 2935 (2021).","journal-title":"Nat. Commun."},{"key":"8758_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41590-021-00903-7","volume":"22","author":"G Barbet","year":"2021","unstructured":"Barbet, G. et al. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming. Nat. Immunol. 22, 497\u2013509 (2021).","journal-title":"Nat. Immunol."},{"key":"8758_CR52","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41551-023-01014-4","volume":"7","author":"H Hao","year":"2023","unstructured":"Hao, H. et al. Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogel. Nat. Biomed. Eng. 7, 928\u2013942 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"8758_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1211\/0022357056280","volume":"57","author":"DG Lendemans","year":"2005","unstructured":"Lendemans, D. G., Myschik, J., Hook, S. & Rades, T. Immuno-stimulating complexes prepared by ethanol injection. J. Pharm. Pharmacol. 57, 729\u2013733 (2005).","journal-title":"J. Pharm. Pharmacol."},{"key":"8758_CR54","doi-asserted-by":"publisher","first-page":"e29115","DOI":"10.1002\/jmv.29115","volume":"95","author":"B Li","year":"2023","unstructured":"Li, B. et al. A conserved N protein nano-vaccine of COVID-19 exerts potent and cross-reactive humoral and cellular immune responses in mice. J. Med. Virol. 95, e29115 (2023).","journal-title":"J. Med. Virol."},{"key":"8758_CR55","doi-asserted-by":"publisher","unstructured":"Tada, T., Peng, J. Y., Dcosta, B. M. & Landau, N. R. Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal model. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.167306 (2023).","DOI":"10.1172\/jci.insight.167306"},{"key":"8758_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2244084","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen. Emerg. Microbes Infect. 12, 2244084 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"8758_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34633-7","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain. Nat. Commun. 13, 6866 (2022).","journal-title":"Nat. Commun."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08758-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:33:05Z","timestamp":1746505985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08758-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":57,"journal-issue":{"issue":"8061","published-print":{"date-parts":[[2025,5,1]]}},"alternative-id":["8758"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-08758-w","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W., X.W., Z.H., L.S., J.J. and C.D. are inventors on a patent related to the ER-targeting technology (ZL202111251211.9). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}